These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
716 related articles for article (PubMed ID: 10815938)
21. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. Joseph IB; Isaacs JT Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270 [TBL] [Abstract][Full Text] [Related]
22. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line. Kondo Y; Arii S; Mori A; Furutani M; Chiba T; Imamura M Clin Cancer Res; 2000 Feb; 6(2):622-30. PubMed ID: 10690548 [TBL] [Abstract][Full Text] [Related]
23. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells. Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894 [TBL] [Abstract][Full Text] [Related]
24. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Araki S; Omori Y; Lyn D; Singh RK; Meinbach DM; Sandman Y; Lokeshwar VB; Lokeshwar BL Cancer Res; 2007 Jul; 67(14):6854-62. PubMed ID: 17638896 [TBL] [Abstract][Full Text] [Related]
25. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Shi Q; Abbruzzese JL; Huang S; Fidler IJ; Xiong Q; Xie K Clin Cancer Res; 1999 Nov; 5(11):3711-21. PubMed ID: 10589791 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor. Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694 [TBL] [Abstract][Full Text] [Related]
27. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764 [TBL] [Abstract][Full Text] [Related]
28. Expression of metastasis-related genes in human epithelial ovarian tumors. Herrera CA; Xu L; Bucana CD; Silva el VG; Hess KR; Gershenson DM; Fidler IJ Int J Oncol; 2002 Jan; 20(1):5-13. PubMed ID: 11743636 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice. Karashima T; Sweeney P; Slaton JW; Kim SJ; Kedar D; Izawa JI; Fan Z; Pettaway C; Hicklin DJ; Shuin T; Dinney CP Clin Cancer Res; 2002 May; 8(5):1253-64. PubMed ID: 12006546 [TBL] [Abstract][Full Text] [Related]
30. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Kim SJ; Uehara H; Karashima T; Mccarty M; Shih N; Fidler IJ Neoplasia; 2001; 3(1):33-42. PubMed ID: 11326314 [TBL] [Abstract][Full Text] [Related]
31. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726 [TBL] [Abstract][Full Text] [Related]
32. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice. Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958 [TBL] [Abstract][Full Text] [Related]
34. Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Huang S; Bucana CD; Van Arsdall M; Fidler IJ Oncogene; 2002 Apr; 21(16):2504-12. PubMed ID: 11971185 [TBL] [Abstract][Full Text] [Related]
35. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995 [TBL] [Abstract][Full Text] [Related]
36. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
37. Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines. Stearns ME; Wang M; Hu Y; Garcia FU; Rhim J Clin Cancer Res; 2003 Mar; 9(3):1191-9. PubMed ID: 12631625 [TBL] [Abstract][Full Text] [Related]
38. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel. Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704 [TBL] [Abstract][Full Text] [Related]
39. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis. Downing S; Bumak C; Nixdorf S; Ow K; Russell P; Jackson P Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098 [TBL] [Abstract][Full Text] [Related]